Systematic Review of Sex-specific High Sensitivity Cardiac Troponin I and T Thresholds

Mengchen Cao1, Ava E Pierce1, Marquita S Norman1

  • 1Department of Emergency Medicine, UT Southwestern Medical Center, Dallas, Texas.

Clinical Therapeutics
|November 6, 2024
PubMed

Insights

High-sensitivity cardiac troponin assays show lower 99th percentiles in females. Adopting these sex-specific thresholds can improve acute myocardial infarction diagnosis in women.

Area of Science:

  • Cardiology
  • Biomarkers
  • Sex-Specific Medicine

Background:

  • High-sensitivity cardiac troponin I (hs-cTnI) and T (hs-cTnT) assays have established 99th percentiles, but lower female thresholds are often overlooked.
  • Clinical underdiagnosis of acute myocardial infarction (AMI) in females may result from the non-adoption of sex-specific troponin cut-offs.
  • This systematic review investigates sex-specific 99th percentiles for hs-cTnI and hs-cTnT in healthy populations.

Approach:

  • A systematic review adhering to PRISMA guidelines was conducted.
  • Searches of PubMed and OVID EMBASE identified studies published between November 2017 and November 2021.
  • Inclusion criteria specified healthy adult reference populations (>300 participants) using high-sensitivity troponin assays with independently derived, sex-specific 99th percentiles.

Key Points:

  • Nineteen studies met the inclusion criteria, analyzing 11 hs-cTnI and 9 hs-cTnT assays.
  • Over 90% of hs-cTnI assays and 88.9% of hs-cTnT assays revealed lower 99th percentiles in females compared to males and overall populations.
  • One study with multiple hs-cTnI assays found only one assay with higher female 99th percentiles.

Conclusions:

  • The findings confirm significantly lower 99th percentiles for hs-cTn in females across various assays.
  • Implementing sex-specific 99th percentile cut-offs in clinical practice is crucial for accurate AMI diagnosis in women.
  • Adoption of these thresholds may lead to improved diagnostic accuracy and patient outcomes for females experiencing AMI.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
103
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
61
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7